M Lader. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAnimalsAnti-Anxiety Agents/pharmacologyAnti-Anxiety Agents/therapeutic useAnxiety/chemically inducedAnxiety/complicationsAnxiety/drug therapyAnxiety/metabolismAnxiety/physiopathologyAnxiety Disorders/physiopathologyArousalBenzodiazepinesBrain/physiopathologyBrain ChemistryCatecholamines/metabolismCatecholamines/physiologyCerebral Ventricles/metabolismCognitionHumansModels, BiologicalPropranolol/therapeutic useStress, Physiological/complicationsSympatholytics/therapeutic useSympathomimetics/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsAnti-Anxiety AgentsCatecholaminesSympatholyticsSympathomimeticsBenzodiazepinesPropranolol
Year: 1974 PMID: 4154319 DOI: 10.1159/000468126
Source DB: PubMed Journal: Int Pharmacopsychiatry ISSN: 0020-8272